Lymphocide: Cytokines and the control of lymphoid homeostasis

Nature Reviews Immunology

Volumn 2, Issue 11, 2002, Pages 817-830

  Khaled, Annette R ^a   Durum, Scott K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; B7 ANTIGEN; CASPASE 9; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOSE TRANSPORTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL 2 BINDING PROTEIN, BIM; BCL-2-BINDING PROTEIN, BIM; CARRIER PROTEIN; CASPASE; FAS ANTIGEN; GLUCOSE; MEMBRANE PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; B LYMPHOCYTE; CELL DEATH; CELL PH; CELL SURVIVAL; DENDRITIC CELL; ENZYME ACTIVATION; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; METABOLISM; PH; PHYSIOLOGY; TRANSGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD95; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CASPASES; CELL DEATH; CYTOKINES; GLUCOSE; HOMEOSTASIS; HUMANS; HYDROGEN-ION CONCENTRATION; LYMPHOCYTES; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 0036831818     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri931     Document Type: Review

References (156)

1. Tanchot, C. et al. Lymphocyte homeostasis. Semin. Immunol. 9, 331-337 (1997).
2. Tanchot, C., Fernandes, H. V. & Rocha, B. The organization of mature T-cell pools. Philos. Trans. R. Soc. Lond. B 355, 323-328 (2000).
3. Rocha, B., Dautigny, N. & Pereira, P. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol. 19, 905-911 (1989).
4. Kieper, W. C. & Jameson, S. C. Homeostatic expansion and phenotypic conversion of naive T cells in response to self-peptide/MHC ligands. Proc. Natl Acad. Sci. USA 96, 13306-13311 (1999).
5. Freitas, A. A. & Rocha, B. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18, 83-111 (2000). This article provides a thorough review of experimental data supporting the concept that there are limits that control the size of lymphocyte populations and that each lymphocyte subset occupies a unique environmental niche.
6. + T cells. Nature Immunol. 1, 107-111 (2000).
7. von Boehmer, H. & Hafen, K. The life span of naive αβ T cells in secondary lymphoid organs. J. Exp. Med. 177, 891-896 (1993).
8. Lodolce, J. P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669-676 (1998).
9. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T-cell lineages in interleukin-15-deficient mice. J. Exp. Med. 191, 771-780 (2000). An evaluation of IL-15-deficient mice, providing evidence that this cytokine is essential for the development of many types of immune cell.
10. Tan, J. T. et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl Acad. Sci. USA 98, 8732-8737 (2001). Definitive proof that IL-7 is required for the maintenance of naive T cells.
11. + T cells.
12. + cells. J. Exp. Med. 195, 1523-1532 (2002).
13. + T cells. J. Exp. Med. 195, 1533-1539 (2002).
14. Kitazawa, H. et al. IL-7 activates α4β1 integrin in murine thymocytes. J. Immunol. 159, 2259-2264 (1997).
15. Ge, Q. et al. Homeostatic T-cell proliferation in a T-cell-dendritic-cell coculture system. Proc. Natl Acad. Sci. USA 99, 2983-2988 (2002).
16. Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001).
17. + T cells.
18. Lam, K. P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997).
19. Pric, M. et al. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167, 5664-5668 (2001).
20. Siegel, R. M. et al. The multifaceted role of Fas signaling in immune-cell homeostasis and autoimmunity. Nature Immunol 1, 469-474 (2000).
21. Hildeman, D. A. et al. Molecular mechanisms of activated T-cell death in vivo. Curr. Opin. Immunol. 14, 354-359 (2002).
22. Schuster, N. & Krieglstein, K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 307, 1-14 (2002).
23. Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46-53 (2002).
24. Nosaka, T. et al. Defective lymphoid development in mice lacking Jak3. Science 270, 800-802 (1995).
25. Van Panjs, L. et al. Uncoupling IL-2 signals that regulate T-cell proliferation, survival and Fas-mediated activation-induced cell death. Immunity 11, 281-288 (1999).
26. Venkitaraman, A. R. & Cowling, R. J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α-chain of the interleukin-7 receptor. Eur. J. Immunol. 24, 2168-2174 (1994).
27. Porter, B. O., Scibelli, P. & Malek, T. R. Control of T-cell development in vivo by subdomains within the IL-7 receptor α-chain cytoplasmic tail. J. Immunol. 166, 262-269 (2001).
28. Guthridge, M. A. et al. Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol. Cell 6, 99-108 (2000).
29. Butler, M. P. et al. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24, 322-327 (1999).
30. Suzuki, A. et al. T-cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523-534 (2001).
31. Fruman, D. A. et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999)
32. Sasaki, T. et al. Function of PI3Kγ in thymocyte development, T-cell activation and neutrophil migration. Science 287, 1040-1046 (2000).
33. Exley, M. & Varticovski, L. Evidence for phosphatidylinositol 3-kinase-dependent T-cell antigen receptor (TCR) signal transduction. Mol. Immunol. 34, 221-226 (1997).
34. Eder, A. M. et al. Phosphoinositide 3-kinase regulation of T-cell-receptor-mediated interleukin-2 gene expression in normal T cells. J. Biol. Chem. 273, 28025-28031 (1998).
35. Kelly, E. et al. IL-2 and related cytokines can promote T-cell survival by activating AKT. J. Immunol. 168, 597-603 (2002).
36. Parsons, M. J. et al. Expression of active protein kinase B in T cells perturbs both T- and B-cell homeostasis and promotes inflammation. J. Immunol. 167, 42-48 (2001).
37. Plas, D. R. et al. Akt and Bcl-xL promote growth-factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276, 12041-12048 (2001).
38. Voll, R. E. et al. NF-κB activation by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development. Immunity 13, 677-689 (2000).
39. Karin, M. & Lin, A. NF-κB at the crossroads of life and death. Nature Immunol. 3, 221-227 (2002).
40. Pohl, T. et al. The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B-cell lineage are restricted to the activation and function of mature cells. Proc. Natl Acad. Sci. USA 99, 4514-4519 (2002).
41. Dexter, T. M., Heyworth, C. M. & Whetton, A. D. The role of haemopoietic cell growth factor (interleukin-3) in the development of haemopoietic cells. Ciba Found. Symp. 116, 129-147 (1985).
42. Garland, J. M. & Halestrap, A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J. Biol. Chem. 272, 4680-4688 (1997).
43. Summers, S. A. & Birnbaum, M. J. A role for the sedne/threonine kinase, Akt, in insulin-stimulated glucose uptake. Biochem. Soc. Trans. 25, 981-988 (1997).
44. Plas, D. R. & Thompson, C. B. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13, 75-78 (2002).
45. Cho, H. et al. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352 (2001).
46. Vander, H. M. et al. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899-5912 (2001). This article provides a thorough evaluation of the role of glucose metabolism in the survival of IL-3-dependent cells, comparing the effects of glucose withdrawal with loss of cytokine signalling in a cell line.
47. Frank, S. et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515-525 (2001).
48. Desagher, S. & Martinou, J. C. Mitochondria as the central control point of apoptosis. Trends Cell. Biol. 10, 369-377 (2000).
49. Puceat, M. pHi regulatory ion transporters: an update on structure, regulation and cell function. Cell. Mol. Life Sci. 55, 1216-1229 (1999)
50. + exchanger. Biochem. Cell. Biol. 76, 735-741 (1998).
51. + exchanger isoform-1. J. Biol. Chem. 274, 20206-20214 (1999).
52. + exchange. J. Biol. Chem 276, 15794-15800 (2001).
53. Khaled, A. R. et al. Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol. Cell. Biol. 21, 7545-7557 (2001). A dissection of the intracellular signalling pathway that is activated by cytokine withdrawal that induces a rise in cytosolic pH.
54. Kummer, J. L., Rao, P. K. & Heidenreich, K. A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 20490-20494 (1997).
55. Rajnavolgyi, E. et al. IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases. Cell. Signal. 14, 761-769 (2002).
56. - exchange and ERK1/2. Circ. Res. 83, 824-831 (1998).
57. Khaled, A. R. et al. Interleukin-3 withdrawal induces an early increase in mitochondrial membrane potential unrelated to the Bcl-2 family. Roles of intracellular pH, ADP transport and F(0)F(1)-ATPase. J. Biol. Chem. 276, 8453-8462 (2001).
58. Khaled, A.R. et al. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA 96, 14476-14481 (1999).
59. Rebollo, A. et al. Apoptosis induced by IL-2 withdrawal is associated with an intracellular acidification. Exp. Cell Res, 218, 581-585 (1995).
60. Matsuyama, S. et al. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nature Cell Biol. 2, 318-325 (2000).
61. Famulski, K. S. et al. Activation of a low pH-dependent nuclease by apoptotic agents. Cell Death Differ 6, 281-289 (1999).
62. Waterhouse, N. J. et al. Cytochrome c maintains mitochonddal transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol. 153, 319-328 (2001).
63. Marzo, I. et al. Caspases disrupt mitochondrial membrane carrier function. FEBS Lett. 427, 198-202 (1998).
64. Chao, D. T. & Korsmeyer, S. J. BCL-2 family: regulators of cell death. Annu Rev. Immunol. 16, 395-419 (1998).
65. Cory, S. Regulation of lymphocyte survival by the Bcl-2 gene family. Annu. Rev. Immunol. 13, 513-543 (1995).
66. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442 (1988).
67. O'Reilly, L. A., Huang, D. C. & Strasser, A. The cell-death inhibitor Bcl-2 and its homologues influence control of cell-cycle entry. EMBO J. 15, 6979-6990 (1996).
68. Veis, D. J. et al. Bcl-2-defcient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75, 229-240 (1993).
69. Matsuzaki, Y. et al. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 89, 853-862 (1997).
70. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-X-defcient mice. Science 267, 1506-1510 (1995).
71. Sentman, C. L. et al. Bcl-2 inhibits multiple forms of apoptosis, but not negative selection, in thymocytes. Cell 67, 879-888 (1991).
72. Strasser, A. et al. Lessons from Bcl-2-transgenic mice for immunology, cancer biology and cell-death research. Behring Inst. Mitt. 97, 101-117 (1996).
73. Ogilvy, S. et al. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor-cell survival. Proc. Natl Acad. Sci. USA 96, 14943-14948 (1999). Expression of a Bcl-2 transgene under the control of a Vav promoter enabled the authors to show the effects of overexpression of Bcl-2 on cells of the immune system.
74. Robles, A. I. et al. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc. Natl Acad. Sci. USA 93, 7634-7638 (1996).
75. Akashi, K. et al. Bcl-2 rescues T lymphopoiesis in interleukin-7-receptor-deficient mice. Cell 89, 1033-1041 (1997).
76. -/- mice. Cell 89, 1011-1019 (1997).
77. Rodewald, H. R., Waskow, C. & Haller, C. Essential requirement for c-kit and common γ-chain in thymocyte development cannot be overruled by enforced expression of Bcl-2. J. Exp. Med. 193, 1431-1437 (2001).
78. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
79. Wolter K. G. et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292 (1997).
80. Goping, I. S. et al. Regulated targeting of BAX to mitochondria J. Cell Biol. 143, 207-215 (1998).
81. Knudson, C. M. et al. Bax-deficient mice with lymphoid hyperplasia and male germ-cell death. Science 270, 96-99 (1995).
82. Wen, R. et al. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol. Cell Biol. 21, 678-689 (2001).
83. Khaled, A. R. et al. Bax defciency partially corrects interleukin-7 receptor-α defciency. Immunity (in the press).
84. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000). A discussion of the phenotype of Bax and Bak double-deficient mice in terms of the effects of loss of these pro-apoptotic proteins on the development of a functional immune system.
85. Wei, M. C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
86. Goldrath, A. W., Bogatzki, L. Y. & Bevan, M. J. Naive T cells transiently acquire a memory-like phenotype during homeostasis-dnven proliferation. J. Exp. Med. 192, 557-564 (2000).
87. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis and to preclude autoimmunity. Science 286, 1735-1738 (1999). The phenotype of Bim-deficient mice is discussed in relation to apoptosis and immune cells.
88. Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922-926 (2002).
89. Yang, E. et al. Bad, a heterodimeric partner for Bcl-X and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291 (1995).
90. Mok, C. L. et al. Bad can act as a key regulator of T-cell apoptosis and T-cell development. J. Exp. Med. 189, 575-586 (1999).
91. Downward, J. How BAD phosphorylation is good for survival Nature Cell Biol. 1, E33-E35 (1999).
92. Kim, K. et al. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1,-T2 and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways J. Immunol. 160, 5735-5741 (1998).
93. Zheng, T. S. & Flavell, R. A. Divinations and surpnses: genetic analysis of caspase function in mice. Exp. Cell. Res. 256, 67-73 (2000).
94. Doerfler, P., Forbush, K. A. & Perlmutter, R. M. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164, 4071-4079 (2000).
95. Wang, J. & Lenardo, M. J. Roles of caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies. J. Cell. Sci. 113, 753-757 (2000).
96. Shin, M. S. et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99, 4094-4099 (2002).
97. Zou, H. et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413 (1997).
98. Hu, Y. et al. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18, 3586-3595 (1999).
99. Adrain, C. & Martin, S. J. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem. Sci. 26, 390-397 (2001).
100. Cardone, M. H. et al. Regulation of cell-death protease caspase-9 by phosphorylation. Science 282, 1318-1321 (1998).
101. Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
102. Hara, H. et al. The apoptotic protease-activating factor-1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J. Immunol. 168, 2288-2295 (2002).
103. Bidere, N. & Senik, A. Caspase-independent apoptotic pathways in T lymphocytes: a minireview. Apoptosis 6, 371-375 (2001).
104. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
105. Hegde, R. et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277, 432-438 (2002).
106. Deveraux, Q. L. et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223 (1998).
107. Du, C. et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42 (2000).
108. Hadin, H. et al. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21, 3604-3608 (2001).
109. Geiselhart, L. A. et al. IL-7 administration alters the CD4:CD8 ratio, increases T-cell numbers and increases T-cell function in the absence of activation. J. Immunol. 166, 3019-3027 (2001).
110. Komschlies, K. L. et al. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T-cell subsets, enhances T-cell function and induces regression of established metastases J. Immunol. 152, 5776-5784 (1994).
111. Mackall, C. L. et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone-marrow transplantation. Blood 97, 1491-1497 (2001).
112. Maki, K. et al. Interleukin-7-receptor-deficient mice lack γδ T cells. Proc. Natl Acad. Sci. USA 93, 7172-7177 (1996).
113. Candeias, S. et al. Defective T-cell receptor γ gene rearrangement in interleukin-7 receptor knockout mice. Immunol. Lett. 57, 9-14 (1997).
114. Gross, J. A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999 (2000).
115. Surh, C. D. & Sprent, J. Regulation of naive and memory T-cell homeostasis. Microbes Infect. 4, 51-56 (2002).
116. Sprent, J. & Surh, C. D. T-cell memory. Annu. Rev. Immunol. 20, 551-579 (2002). An excellent review of recent findings on the origins and regulation of memory T cells.
117. Marks-Konczalik, J. et al. IL-2-induced activation-induced cell death is inhibited in IL-15-transgenic mice. Proc. Natl Acad. Sci. USA 97, 11445-11450 (2000).
118. Rich, B. E. et al. Cutaneous lymphoproliferation and lymphomas in interleukin-7-transgenic mice. J. Exp. Med. 177, 305-316 (1993).
119. Mertsching, E., Burdet, C. & Ceredig, R. IL-7-transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int. Immunol. 7, 401-414 (1995).
120. Fehniger, T. A. et al. Fatal leukemia in interleukin-15-transgenic mice follows early expansions in natural killer and memory phenotype CD8-T cells. J. Exp. Med. 193, 219-231 (2001).
121. Thomis, D. C. & Berg, L. J. Penpheral expression of Jak3 is required to maintain T-lymphocyte function. J. Exp. Med. 185, 197-206 (1997).
122. Dumon, S. et al. IL-3-dependent regulation of Bcl-xL gene expression by STAT5 in a bone-marrow-dedved cell line. Oncogene 18, 4191-4199 (1999).
123. Heckman, C. A., Mehew, J. W. & Boxer, L. M. NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 21, 3898-3908 (2002).
124. Cantrell, D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14, 19-26 (2002).
125. del-Peso, L. et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689 (1997).
126. Griffiths, G. J. et al. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene 20, 7668-7676 (2001).
127. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).
128. Puthalakath, H. et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell. 3, 287-296 (1999).
129. Dijkers, P. F. et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10, 1201-1204 (2000).
130. Sugiyama, T. et al. Activation of mitochonddal voltage-dependent anion channel by a pro-apoptotic BH3-only protein Bim. Oncogene 21, 4944-4956 (2002).
131. Khaled, A. R. & Durum, S. From cytosol to mitochondria: the Bax translocation story. J. Biochem. Mol. Biol. 34, 391-394 (2001).
132. Belaud-Rotureau, M. A. et al. Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis 5, 551-560 (2000).
133. Tsuruta, F., Masuyama, N. & Gotoh, Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277, 14040-14047 (2002).
134. Desagher, S. et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901 (1999).
135. Marani, M. et al. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol. 22, 3577-3589 (2002).
136. Zong, W. X. et al. BH3-only proteins that bind pro-survrval Bcl-2-family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481-1486 (2001).
137. Saito, M., Korsmeyer, S. J. & Schlesinger, P. H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nature Cell Biol. 2, 553-555 (2000).
138. Shimizu, S., Narita, M. & Tsujimoto, Y. Bcl-2-family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487 (1999).
139. Leonard, W. J. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine-receptor signaling. Annu. Rev. Med. 47, 229-239 (1996).
140. DiSanto, J. P. et al. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor γ-chain. Proc. Natl Acad. Sci. USA 92, 377-381 (1995).
141. von-Freeden-Jeffry, U. et al. Lymphopenia in intedeukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526 (1995).
142. Peschon, J. J. et al. in Cytokine Knockouts (eds Durum, S. K. & Muegge, K.) 37-52 (Humana, Totowa, New Jersey, 1998).
143. + T cell, but not natural killer cells. J. Exp. Med. 184, 289-293 (1996).
144. Thomis, D. C. et al. Defects in B-lymphocyte maturation and T-lymphocyte activation in mice lacking Jak3. Science 270, 794-797 (1995).
145. Rolink, A. G. & Melchers, F. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14, 266-275 (2002).
146. Walsh, C. M. et al. A role for FADD in T-cell activation and development. Immunity 8, 439-449 (1998)
147. Kabra, N. H. et al. T-cell-specific FADD-deficient mice: FADD is required for eady T-cell development. Proc. Natl Acad. Sci. USA 98, 6307-6312 (2001).
148. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390-392 (1999).
149. Chen, W. S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (2001).
150. Brady, H. J. et al. T cells from Baxα-transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53, gene product in. EMBO J. 15, 1221-1230 (1996).
151. Sadlack, B. et al. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur. J. Immunol. 24, 281-284 (1994).
152. Strasser, A. et al. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann. NY Acad. Sci. 917, 541-548 (2000).
153. Innes, K. M. et al. Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis. Exp. Hematol. 27, 75-87 (1999).
154. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
155. Gorelik, L. & Flavell, R. A. Abrogation of TGFβ signaling in T cells leads to spontaneous T-cell differentiation and autoimmune disease. Immunity 12, 171-181 (2000).
156. Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).